Link to DermNet's pages about injected skin treatments.
- Adalimumab
- Adrenaline
- Afamelanotide
- Alefacept
- Anakinra
- Anaesthetics
- Antibiotics
- Augmentation
- Biological agents for psoriasis
- Biological treatments
- Bleomycin
- Botulinum toxin
- Brodalumab
- Cemiplimab
- Collagen replacement
- Cyclophosphamide
- Deoxycholic acid
- Dupilumab
- Efalizumab
- Etanercept
- Facial implants
- Fat grafting
- Fillers
- Gold
- Guselkumab
- Hyaluronic acid implant
- Hydroxyapatite implant
- Immunoglobulin
- Immunotherapy for allergic diseases
- Immunotherapy for melanoma metastases
- Implants
- Infliximab
- Intralesional injection
- Intralesional steroids
- Ipilimumab
- Isolated limb perfusion
- Ixekizumab
- Lanadelumab
- Lebrikizumab
- Leg vein therapies
- Local anaesthetics
- Melanotan II
- Nivolumab
- Mesotherapy
- Omalizumab
- Pembrolizumab
- Platelet-rich plasma
- Polyacrylamide implants
- Polyethylene implants
- Polymethyl methacrylate implants
- Polytetrafluoroethylene implant
- Posaconazole
- Risankizumab
- Rituximab
- Sclerotherapy
- Secukinumb
- Silicone implant
- Tildrakizumab
- Ustekinumab
- Vaccines for melanoma
New Zealand approved datasheets are the official source of information for prescription medicines, including approved uses and risk information. Check the individual New Zealand datasheet on the Medsafe website.
If you are not based in New Zealand, we suggest you refer to your national drug approval agency for further information about medicines (eg, the Australian Therapeutic Goods Administration and the US Food and Drug Administration) or a national or state-approved formulary (eg, the New Zealand Formulary and New Zealand Formulary for Children and the British National Formulary and British National Formulary for Children).